Treatment of low-grade non-Hodgkin's lymphoma with continuous infusion of low-dose recombinant interleukin-2 in combination with the B-cell-specific monoclonal antibody CLB-CD19
暂无分享,去创建一个
J. Sein | A. Hekman | C. Melief | F. Vyth-Dreese | E. Rankin | A. Voordouw | L. Vlasveld | T. Dellemijn | C. J. Melief | A. Hekman | E. Rankin | L. Vlasveld | F. Vyth-Dreese | J. Sein | A. Voordouw | T. Dellemijn